Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Novavax, Inc. (NVAX) had Stock-Based Compensation of $36.02M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$1.12B |
|
$440.30M |
|
$73.04M |
|
$1.05B |
|
$670.68M |
|
$452.80M |
|
$-10.63M |
|
$442.17M |
|
$442.17M |
|
$440.30M |
|
$440.30M |
|
$440.30M |
|
$440.30M |
|
$452.80M |
|
$480.41M |
|
161.99M |
|
173.10M |
|
$2.72 |
|
$2.58 |
|
| Balance Sheet Financials | |
$978.28M |
|
$44.80M |
|
$198.24M |
|
$1.18B |
|
$459.95M |
|
$246.30M |
|
$844.32M |
|
$1.30B |
|
$-127.75M |
|
$-241.22M |
|
$-127.75M |
|
162.58M |
|
| Cash Flow Statement Financials | |
$-244.63M |
|
$-78.27M |
|
$27.74M |
|
$545.29M |
|
$256.05M |
|
$-289.24M |
|
|
Stock-Based Compensation |
$36.02M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.13 |
|
-- |
|
-- |
|
2.08 |
|
-1.95 |
|
93.50% |
|
40.30% |
|
40.30% |
|
42.76% |
|
39.36% |
|
39.19% |
|
$-250.19M |
|
-- |
|
-- |
|
-- |
|
0.95 |
|
6.33 |
|
10.55 |
|
34.58 |
|
-344.65% |
|
-182.53% |
|
37.42% |
|
371.40% |
|
$-0.79 |
|
$-1.45 |
|
$-1.41 |
|